Search clinical trials for: PEX168

Total 26 results

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients

Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Type 2 Diabetes Mellitus

China
Jiangsu HengRui Medicine Co., Ltd.
Beijing Tongren Hospital

Completed

A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.
People's Liberation Army General Hospital of Chengdu Military Region

Completed

A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Type 2 Diabetes Mellitus

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Healthy
Jiangsu HengRui Medicine Co., Ltd.
China-Japan Friendship Hospital

Completed

A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Type 2 Diabetes

China
ChemoCentryx

Completed

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

Hidradenitis Suppurativa | Acne Inversa

United States
ChemoCentryx

Completed

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

Immunoglobulin A Nephropathy

United States, Sweden
Mario Negri Institute for Pharmacological Research
ChemoCentryx

Terminated

Complement Inhibition in aHUS Dialysis Patients (ACCESS)

Atypical Hemolytic Uremic Syndrome

Italy
ChemoCentryx
Medpace, Inc.

Completed

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy (ACCOLADE)

C3 Glomerulopathy (C3G)

United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
Amgen

Completed

A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

United States
Amgen

Completed

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

United States
Amgen

Completed

A Study of CCX168 in Japanese and Caucasian Healthy Adult Males

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Japan
Amgen

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants

Vasculitis | Systemic Lupus Erythematosus (SLE)

Switzerland
Amgen

Completed

A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Impairment

Hepatic Impairment

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects

Type 2 Diabetes Mellitus

China
Amgen

Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Antineutrophil Cytoplasmic Antibody-associated Vasculitis

United States
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis

Vasculitis

France, United Kingdom, Germany, Belgium, Poland, Netherlands, Hungary, Austria, Sweden, Czechia
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects

Healthy

China
First Affiliated Hospital Xi'an Jiaotong University

Completed

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects

Healthy

China
Fudan University

Recruiting

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Obesity | Atypical Endometrial Hyperplasia | Fertility Issues

China
Amgen

Completed

Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin

Healthy Volunteers

United States
ChemoCentryx

Completed

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

ANCA-associated Vasculitis

United States, Canada
ChemoCentryx

Completed

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)

ANCA-Associated Vasculitis

United States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
Amgen

Completed

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

United States

Search clinical trials for: PEX168

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations